News & Publications

Wound care news hand-picked for you.

Apr
17

Clinical Study Finds Burn Patients Treated with Kerecis® Omega3 Intact Fish Skin Experienced Pain Relief, Fast Healing and No Infections

Kerecis, the company pioneering the use of fish skin in tissue regeneration, today announced the results of a new prospective case study of Kerecis Omega3 Burn. The study, announced at the American Burn Association annual meeting, found that patients with partial-thickness burn and donor-site wounds healed quickly, with no infection, after treatment with the fish-skin graft.

Read More
Apr
17

The effects of graphene and mesenchymal stem cells in cutaneous wound healing and their putative action mechanism

This study provides a review of the therapeutic potential of graphene dressing scaffolds and mesenchymal stem cells (MSCs) and their synergistic effects with respect to cutaneous wound healing. This study also considers their putative action mechanism based on the antibacterial, immunomodulating, angiogenic, matrix remodeling effects of materials belonging to the graphene family and MSCs during the wound healing process.

Read More
Apr
17

Injectable Self‐Healing Antibacterial Bioactive Polypeptide‐Based Hybrid Nanosystems for Efficiently Treating Multidrug Resistant Infection, Skin‐Tumor Therapy, and Enhancing Wound Healing

The surgical procedure in skin‐tumor therapy usually results in cutaneous defects, and multidrug‐resistant bacterial infection could cause chronic wounds. Here, for the first time, an injectable self‐healing antibacterial bioactive polypeptide‐based hybrid nanosystem is developed for treating multidrug resistant infection, skin‐tumor therapy, and wound healing.

Read More
Apr
15

CMC wound care wins national award

Colleton Medical Center physicians, leaders and clinicians gathered March 19 to celebrate the Robert A. Warriner III, M.D., Center of Excellence award, which was given to Advanced Wound Care Clinic. This center has achieved patient satisfaction rates higher than 92 percent and a healing rate of at least 91 percent in less than 30 median days to heal for a minimum of two consecutive years.

Read More